Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2024 Volume 30 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2024 Volume 30 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells

  • Authors:
    • Baogui Wang
    • Haibo Xu
    • Shuai Shang
    • Longxiang Liu
    • Chunlong Sun
    • Wen Du
  • View Affiliations / Copyright

    Affiliations: School of Healthy Aging, Shandong Women's University, Jinan, Shandong 250000, P.R. China, Department of Biological and Environmental Engineering, Binzhou University, Binzhou, Shandong 256600, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 240
    |
    Published online on: October 15, 2024
       https://doi.org/10.3892/mmr.2024.13364
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Abnormal mitohormesis is a key pathogenic mechanism that induces a variety of cardiac diseases, including cardiac hypertrophy and heart failure. Irisin as a muscle factor serves a cardioprotective role in response to cellular oxidative stress injury. Rat cardiomyocyte cells (H9c2) were treated with 40 µM exogenous H2O2 to establish an oxidative stress model, followed by addition of 75 nM exogenous irisin for experiments to determine mitochondrial membrane potential, reactive oxygen species, and Mitohormesis‑related factors by attrition cytometry. Subsequently, the expression of mitochondrial membrane potential, reactive oxygen species and Mitohormesis‑related factors were continued to be determined by establishing a peroxisome proliferator‑activated receptor γ coactivator‑1 alpha (PGC‑1α) siRNA interference model and continuing the treatment with the addition of 75 nM irisin 12 h before the end of interference. When H9c2 cells underwent oxidative stress, irisin partially improved mitochondrial membrane potential and reactive oxygen species levels and partially restored mitochondrial energy metabolism by upregulating fusion proteins optic atrophy 1 (OPA1) mitochondrial dynamin‑like GTPase and mitofusin 2 and downregulating fission protein dynamin‑related protein 1. Following interference with PGC‑1α, irisin promoted mitochondrial biosynthesis by increasing the mRNA levels of OPA1 and protein levels of cytochrome c oxidase subunit 4. These results suggested that irisin acted partially independently of the PGC‑1α signaling pathway to regulate mitohormesis imbalance due to oxidative stress and maintain energy metabolism by improving mitochondrial structure.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Yun J and Finkel T: Mitohormesis. Cell Metab. 19:757–766. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Li A, Zheng N and Ding X: Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress. Heart Fail Rev. 27:1387–1394. 2022. View Article : Google Scholar : PubMed/NCBI

3 

Ni HM, Williams JA and Ding WX: Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 4:6–13. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Jiao H, Jiang D, Hu X, Du W, Ji L, Yang Y, Li X, Sho T, Wang X, Li Y, et al: Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell. 184:2896–2910.e13. 2021. View Article : Google Scholar : PubMed/NCBI

5 

Chen Q, Chen L, Jian J, Li J and Zhang X: The mechanism behind BAF60c in myocardial metabolism in rats with heart failure is through the PGC1α-PPARα-mTOR signaling pathway. Bioch Cell Biol. 100:93–103. 2022. View Article : Google Scholar

6 

Meliț LE, Mărginean CO, Mărginean CD and Săsăran MO: The peculiar trialogue between pediatric obesity, systemic inflammatory status, and immunity. Biology. 10:5122021. View Article : Google Scholar : PubMed/NCBI

7 

Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, et al: A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 481:463–468. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Zhang H, Wu X, Liang J, Kirberger M and Chen N: Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process. Ageing Res Rev. 80:1016802022. View Article : Google Scholar : PubMed/NCBI

9 

Fox J, Rioux BV, Goulet EDB, Johanssen NM, Swift DL, Bouchard DR, Loewen H and Sénéchal M: Effect of an acute exercise bout on immediate post-exercise irisin concentration in adults: A meta-analysis. Scand J Med Sci Sports. 28:16–28. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Jandova T, Buendía-Romero A, Polanska H, Hola V, Rihova M, Vetrovsky T, Courel-Ibáñez J and Steffl M: Long-term effect of exercise on Irisin blood levels-systematic review and meta-analysis. Healthcare (Basel). 9:14382021. View Article : Google Scholar : PubMed/NCBI

11 

Rejeki PS, Pranoto A, Prasetya RE and Sugiharto S: Irisin serum increasing pattern is higher at moderate-intensity continuous exercise than at moderate-intensity interval exercise in obese females. Comparative Exercise Physiol. 17:475–484. 2021. View Article : Google Scholar

12 

Tsai CL, Pan CY, Tseng YT, Chen FC, Chang YC and Wang TC: Acute effects of high-intensity interval training and moderate-intensity continuous exercise on BDNF and irisin levels and neurocognitive performance in late middle-aged and older adults. Behav Brain Res. 413:1134722021. View Article : Google Scholar : PubMed/NCBI

13 

Han C, Lu P and Yan SZ: Effects of high-intensity interval training on mitochondrial supercomplex assembly and biogenesis, mitophagy, and the AMP-activated protein kinase pathway in the soleus muscle of aged female rats. Exp Gerontol. 158:1116482022. View Article : Google Scholar : PubMed/NCBI

14 

Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM, Nair KS, Gygi SP and Spiegelman BM: Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 22:734–740. 2015.https://doi.org/10.1016/j.cmet.2015.08.001 View Article : Google Scholar : PubMed/NCBI

15 

Flori L, Testai L and Calderone V: The ‘irisin system’: From biological roles to pharmacological and nutraceutical perspectives. Life Sci. 267:1189542021. View Article : Google Scholar : PubMed/NCBI

16 

Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG and Tang QZ: FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 27:540–555. 2020. View Article : Google Scholar : PubMed/NCBI

17 

Hu C, Zhang X, Hu M, Teng T, Yuan YP, Song P, Kong CY, Xu SC, Ma ZG and Tang QZ: Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice. Aging Cell. 21:e135562022. View Article : Google Scholar : PubMed/NCBI

18 

Seo DY, Bae JH, Kim TN, Kwak HB, Kha PT and Han J: Exercise-induced circulating irisin level is correlated with improved cardiac function in rats. Int J Environ Res Public Health. 17:38632020. View Article : Google Scholar : PubMed/NCBI

19 

Li R, Wang X, Wu S, Wu Y, Chen H, Xin J, Li H, Lan J, Xue K, Li X, et al: Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy. J Cell Physiol. 234:17578–17588. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Tu T, Yin S, Pang J, Zhang X, Zhang L, Zhang Y, Xie Y, Guo K, Chen L, Peng J and Jiang Y: Irisin contributes to neuroprotection by promoting mitochondrial biogenesis after experimental subarachnoid hemorrhage. Front Aging Neurosci. 13:6402152021. View Article : Google Scholar : PubMed/NCBI

21 

Zhang L, Liu Y, Li JY Li LZ, Zhang YL, Gong HY and Cui Y: Protective effect of rosamultin against H2O2-induced oxidative stress and apoptosis in H9c2 cardiomyocytes. Oxid Med Cell Longev. 2018:84156102018. View Article : Google Scholar : PubMed/NCBI

22 

Ramachandra CJ, Cong S, Chan X, Yap EP, Yu F and Hausenloy DJ: Oxidative stress in cardiac hypertrophy: From molecular mechanisms to novel therapeutic targets. Free Radic Biol Med. 166:297–312. 2021. View Article : Google Scholar : PubMed/NCBI

23 

Chi RF, Li L, Wang AL, Yang H, Xi J, Zhu ZF, Wang K, Li B, Yang LG, Qin FZ and Zhang C: Enhanced oxidative stress mediates pathological autophagy and necroptosis in cardiac myocytes in pressure overload induced heart failure in rats. Clin Exp Pharmacol Physiol. 49:60–69. 2022. View Article : Google Scholar : PubMed/NCBI

24 

Ganta KK, Mandal A and Chaubey B: Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity. Cell Biol Toxicol. 33:69–82. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Yadav N, Dwivedi A, Mujtaba SF, Verma A, Chaturvedi R, Ray RS and Singh G: Photosensitized mefloquine induces ROS-mediated DNA damage and apoptosis in keratinocytes under ambient UVB and sunlight exposure. Cell Biol Toxicol. 30:253–268. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Li X, Zhang DQ, Wang X, Zhang Q, Qian L, Song R, Zhao X and Li X: Irisin alleviates high glucose-induced hypertrophy in H9c2 cardiomyoblasts by inhibiting endoplasmic reticulum stress. Peptides 152: 170774-. 2022. View Article : Google Scholar

27 

He W, Wang P, Chen Q and Li C: Exercise enhances mitochondrial fission and mitophagy to improve myopathy following critical limb ischemia in elderly mice via the PGC1a/FNDC5/irisin pathway. Skelet Muscle. 10:1–14. 2020. View Article : Google Scholar

28 

Tan Y, Ouyang H, Xiao X, Zhong J and Dong M: Irisin ameliorates septic cardiomyopathy via inhibiting DRP1-related mitochondrial fission and normalizing the JNK-LATS2 signaling pathway. Cell Stress Chaperones. 24:595–608. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Xin T and Lu C: Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction. Aging (Albany NY). 12:4474–4488. 2020. View Article : Google Scholar : PubMed/NCBI

30 

Del Dotto V, Mishra P, Vidoni S, Fogazza M, Maresca A, Caporali L, McCaffery JM, Cappelletti M, Baruffini E, Lenaers G, et al: OPA1 isoforms in the hierarchical organization of mitochondrial functions. Cell Rep. 19:2557–2571. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Wu W, Zhao D, Shah SZA, Zhang X, Lai M, Yang D, Wu X, Guan Z, Li J, Zhao H, et al: OPA1 overexpression ameliorates mitochondrial cristae remodeling, mitochondrial dysfunction, and neuronal apoptosis in prion diseases. Cell Death Dis. 10:7102019.https://doi.org/10.1038/s41419-019-1953-y View Article : Google Scholar : PubMed/NCBI

32 

Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, Menabò R, Costa V, Civiletto G, Pesce P, et al: The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab. 21:834–844. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Huang C, Deng K and Wu M: Mitochondrial cristae in health and disease. Int J Biol Macromol. 235:1237552023. View Article : Google Scholar : PubMed/NCBI

34 

Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, et al: PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3:e1012005. View Article : Google Scholar : PubMed/NCBI

35 

Lu Z, Xu X, Hu X, Fassett J, Zhu G, Tao Y, Li J, Huang Y, Zhang P, Zhao B and Chen Y: PGC-1α regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal. 13:1011–1022. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Huang J, Peng W, Zheng Y, Hao H, Li S, Yao Y, Ding Y, Zhang J, Lyu J and Zeng Q: Upregulation of UCP2 expression protects against LPS-induced oxidative stress and apoptosis in cardiomyocytes. Oxid Med Cell Longev. 2019:27582622019. View Article : Google Scholar : PubMed/NCBI

37 

Liu D, Ma Z, Di S, Yang Y, Yang J, Xu L, Reiter RJ, Qiao S and Yuan J: AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radic Biol Med. 129:59–72. 2018. View Article : Google Scholar : PubMed/NCBI

38 

Xu W, Yan J, Ocak U, Lenahan C, Shao A, Tang J, Zhang J and Zhang JH: Melanocortin 1 receptor attenuates early brain injury following subarachnoid hemorrhage by controlling mitochondrial metabolism via AMPK/SIRT1/PGC-1α pathway in rats. Theranostics. 11:5222021. View Article : Google Scholar : PubMed/NCBI

39 

Wang Y, Zhao X, Lotz M, Terkeltaub R and Liu-Bryan R: Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α. Arthritis Rheumatol. 67:2141–2153. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Zhang GM, Deng MT, Zhang YL, Fan YX, Wan YJ, Nie HT, Wang ZY, Wang F and Lei ZH: Effect of PGC-1α overexpression or silencing on mitochondrial apoptosis of goat luteinized granulosa cells. J Bioenerg Biomembr. 48:493–507. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Ye X, Shen Y, Ni C, Ye J, Xin Y, Zhang W and Ren Y: Irisin reverses insulin resistance in C2C12 cells via the p38-MAPK-PGC-1α pathway. Peptides. 119:1701202019. View Article : Google Scholar : PubMed/NCBI

42 

Bi J, Zhang J, Ren Y, Du Z, Li Q, Wang Y, Wei S, Yang L, Zhang J, Liu C, et al: Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol. 20:296–306. 2019. View Article : Google Scholar : PubMed/NCBI

43 

St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB and Spiegelman BM: Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J Biol Chem. 278:26597–26603. 2003. View Article : Google Scholar : PubMed/NCBI

44 

Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM, Conn CA and Trujillo KA: Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 16:711–718. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Tahrir FG, Langford D, Amini S, Mohseni Ahooyi T and Khalili K: Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease. J Cell Physiol. 234:8122–8133. 2019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang B, Xu H, Shang S, Liu L, Sun C and Du W: Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells. Mol Med Rep 30: 240, 2024.
APA
Wang, B., Xu, H., Shang, S., Liu, L., Sun, C., & Du, W. (2024). Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells. Molecular Medicine Reports, 30, 240. https://doi.org/10.3892/mmr.2024.13364
MLA
Wang, B., Xu, H., Shang, S., Liu, L., Sun, C., Du, W."Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells". Molecular Medicine Reports 30.6 (2024): 240.
Chicago
Wang, B., Xu, H., Shang, S., Liu, L., Sun, C., Du, W."Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells". Molecular Medicine Reports 30, no. 6 (2024): 240. https://doi.org/10.3892/mmr.2024.13364
Copy and paste a formatted citation
x
Spandidos Publications style
Wang B, Xu H, Shang S, Liu L, Sun C and Du W: Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells. Mol Med Rep 30: 240, 2024.
APA
Wang, B., Xu, H., Shang, S., Liu, L., Sun, C., & Du, W. (2024). Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells. Molecular Medicine Reports, 30, 240. https://doi.org/10.3892/mmr.2024.13364
MLA
Wang, B., Xu, H., Shang, S., Liu, L., Sun, C., Du, W."Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells". Molecular Medicine Reports 30.6 (2024): 240.
Chicago
Wang, B., Xu, H., Shang, S., Liu, L., Sun, C., Du, W."Irisin improves ROS‑induced mitohormesis imbalance in H9c2 cells". Molecular Medicine Reports 30, no. 6 (2024): 240. https://doi.org/10.3892/mmr.2024.13364
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team